Companies: 10,795·Total market cap: $144.5T
Pacira BioSciences, Inc.

Pacira BioSciences, Inc.

PCRXNASDAQHealthcare● Active
$22.92
+$0.17(+0.75%)
Market Cap$901554266
P/E Ratio
52W High$27.64
52W Low$18.8

Pacira BioSciences, Inc. (PCRX) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · PCRX · as of Jun 8, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

15

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Pacira BioSciences, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

PCRX insider buying and selling by quarter

PCRX insider selling · PCRX insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
707K353K0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · PCRX ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

PCRX executive sell shares · PCRX board member insider trading · PCRX insider trading SEC filing

Showing 79 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

RIKER LAUREN

Senior Vice President, Finance

Other

Date

Jun 3

Shares

3,187

Price

$22.32

Value

$71K

View Form 4 on SEC.gov

SLONIN JONATHAN

Chief Medical Officer

Other

Date

Jun 3

Shares

4,728

Price

$22.32

Value

$106K

View Form 4 on SEC.gov

WILLIAMS KRISTEN

Chief Administrative Officer

Other

Date

Jun 3

Shares

8,528

Price

$22.32

Value

$190K

View Form 4 on SEC.gov

WILLIAMS KRISTEN

Chief Administrative Officer

Sale

Date

Jun 4

Shares

10,259

Price

$22.27

Value

$228K

View Form 4 on SEC.gov

Cross Shawn

CFO

Option

Date

Apr 23

Shares

12,941

Price

$16.45

Value

$213K

View Form 4 on SEC.gov

Cross Shawn

CFO

Sale

Date

Apr 23

Shares

12,941

Price

$25.16

Value

$326K

View Form 4 on SEC.gov

Cross Shawn

CFO

Option

Date

Apr 20

Shares

7,714

Price

$16.45

Value

$127K

View Form 4 on SEC.gov

Cross Shawn

CFO

Option

Date

Apr 21

Shares

2,845

Price

$16.45

Value

$47K

View Form 4 on SEC.gov

Cross Shawn

CFO

Option

Date

Apr 22

Shares

1,500

Price

$16.45

Value

$25K

View Form 4 on SEC.gov

Cross Shawn

CFO

Sale

Date

Apr 20

Shares

7,714

Price

$25.14

Value

$194K

View Form 4 on SEC.gov

Cross Shawn

CFO

Sale

Date

Apr 22

Shares

1,500

Price

$25.01

Value

$38K

View Form 4 on SEC.gov

SLONIN JONATHAN

Chief Medical Officer

Sale

Date

Mar 17

Shares

3,261

Price

$22.82

Value

$74K

View Form 4 on SEC.gov

Froimson Mark

Director

Sale

Date

Mar 17

Shares

500

Price

$21.81

Value

$11K

View Form 4 on SEC.gov

Cross Shawn

CFO

Award

Date

Feb 11

Shares

49,091

Price

Value

View Form 4 on SEC.gov

WILLIAMS KRISTEN

Chief Administrative Officer

Award

Date

Feb 11

Shares

54,546

Price

Value

View Form 4 on SEC.gov

Teehan Brendan

Chief Commercial Officer

Award

Date

Feb 11

Shares

51,714

Price

Value

View Form 4 on SEC.gov

RIKER LAUREN

Senior Vice President, Finance

Award

Date

Feb 11

Shares

19,273

Price

Value

View Form 4 on SEC.gov

SLONIN JONATHAN

Chief Medical Officer

Award

Date

Feb 11

Shares

54,546

Price

Value

View Form 4 on SEC.gov

Lee Frank D.

CEO · Director

Award

Date

Feb 11

Shares

261,818

Price

Value

View Form 4 on SEC.gov

RIKER LAUREN

Senior Vice President, Finance

Other

Date

Jan 30

Shares

2,751

Price

$20.54

Value

$57K

View Form 4 on SEC.gov

RIKER LAUREN

Senior Vice President, Finance

Sale

Date

Feb 2

Shares

4,000

Price

$20.81

Value

$83K

View Form 4 on SEC.gov

WILLIAMS KRISTEN

Chief Administrative Officer

Other

Date

Jan 30

Shares

17,134

Price

$20.54

Value

$352K

View Form 4 on SEC.gov

WILLIAMS KRISTEN

Chief Administrative Officer

Sale

Date

Feb 2

Shares

13,137

Price

$20.53

Value

$270K

View Form 4 on SEC.gov

SLONIN JONATHAN

Chief Medical Officer

Other

Date

Jan 30

Shares

6,168

Price

$20.54

Value

$127K

View Form 4 on SEC.gov

Teehan Brendan

Chief Commercial Officer

Other

Date

Jan 30

Shares

5,182

Price

$20.54

Value

$106K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 4

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About PCRX insider trading

PCRX insider trades

Pacira BioSciences, Inc. (PCRX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Cross Shawn (CFO), SLONIN JONATHAN (Chief Medical Officer), RIKER LAUREN (Senior Vice President, Finance). Over the past 12 months, 5 insiders have filed transactions with the SEC. PCRX insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Pacira BioSciences, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

PCRX insider trading · 5 questions

The insiders of Pacira BioSciences, Inc. (PCRX) include executives and directors such as Cross Shawn (CFO), SLONIN JONATHAN (Chief Medical Officer), RIKER LAUREN (Senior Vice President, Finance), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

PCRX board member insider tradingwho are PCRX insidersPCRX insider rosterPacira BioSciences, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026